US Bancorp
SRTA

US Bancorp’s Strata Critical Medical Inc SRTA Stock Holding History

US Bancorp’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297 Sell
71
-131
-65% -$631 ﹤0.01% 4059
2025
Q4 		$972 Buy
+202
New +$977 ﹤0.01% 3857

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp's SRTA Position: Q1 2026 in Review

US Bancorp reduced its Strata Critical Medical Inc (SRTA) stake by 65% in Q1 2026, selling an estimated $631 and leaving 71 shares worth $297. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

US Bancorp first reported a position in SRTA in Q4 2025 and has held it in 2 quarters since. The position peaked at $972 in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • US Bancorp held 71 shares of Strata Critical Medical Inc worth $297 as of Q1 2026.
  • US Bancorp sold 131 Strata Critical Medical Inc shares in Q1 2026, an estimated $631.
  • Strata Critical Medical Inc made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #4059 holding.
  • US Bancorp first reported a position in Strata Critical Medical Inc in Q4 2025 and has held it in 2 quarters since.
  • US Bancorp's Strata Critical Medical Inc position peaked at $972 in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.